Skip page top navigation FDA Logo--links to FDA home
page Logo of and Link to start page of Office of Regulatory Affairs, 
U.S. Food and Drug Administration U.S. Food and Drug Administration Office of Regulatory Affairs HHS Logo and link to Department of Health and Human Services website

FDA Home Page | Federal-State | Import Program | Compliance | Inspection | Science | ORA Search

IA #89-07, 8/8/01, "DETENTION WITHOUT PHYSICAL EXAMINATION OF GYNECOLOGICAL
DEVICES MANUFACTURED BY LEIBAN INTERNATIONAL"

NOTE:     This revision is being issued to revise the alert into the current
format and terminology.  Changes are bracketed by asterisks (***).

TYPE OF
ALERT:    *** Detention Without Physical Examination (DWPE)***

     NOTE:     This import alert represents the Agency's current guidance to FDA
               field personnel regarding the manufacturer(s) and/or products(s)
               at issue.  It does not create or confer any rights for or on any
               person, and does not operate to bind FDA or the public.

PRODUCT:  Autoexpandable and Discardable Speculum for Gynecological Use
          Models:  Small #2, Medium #3, Large #4


PRODUCT
CODE:          *** 85H[][][][] ***

PROBLEM:  *** Lacks adequate directions for use ***

PAF:      *** LBL (Labeling) ***

PAC:      *** 82008 ***

COUNTRY:  Argentina (AR)

MANUFACTURER/
SHIPPER:  Lebian International, S.R.L.
          La Pax 1071
          Rosario, Argentina
          FEI# 12587

IMPORTER'S
I.D.#:    ^

                                   ^

CHARGE:   "The article is subject to refusal of admission pursuant to
          Section 801(a)(3), in that it appears that its labeling does not
          bear adequate directions for use [Misbranding, Section
          502(f)(1)]."

OASIS CHARGE
CODE:          DIRECTIONS

RECOMMENDING
OFFICE:   CDRH, OC, (HFZ-323)

REASON FOR
ALERT:    The labeling on the device lacks the information specified in 21
          CFR 801.109.  Therefore, the article is not exempt from the
          requirement in Section 502(f)(1) that it labeling bear adequate
          directions for use.

          Because of the unique autoexpandable feature of the speculum and
          the lack of specific and detailed instructions, the labeling, as
          provided, is inadequate.  The device is unusual and, as such, the
          method and idiosyncrasies of its use will not be completely
          obvious to the clinician.  Detailed instructions and caution
          statements are necessary to eliminate the potential hazard to
          health.  CDRH has informed the law firm representing the
          manufacturer that the devices will be denied entry into the United
          States.

GUIDANCE: Districts may detain without physical examination the devices from
          the firm identified in this alert.

          For questions or issues concerning science, science policy, sample
          collection, analysis, preparation, or analytical methodology,
          contact the Division of Field Science at (301) 827-7605.

PRIORITIZATION
GUIDANCE: N/A

FOI:      Information designated between ^      ^< requires purging.

KEYWORDS: Speculum, OBGYN, Gynecology,

PREPARED
BY:       Ted Poplawski, DIOP, 301-443-6553

DATE LOADED
INTO FIARS: